Fundraising Fox

Nexus Venture Partners2023 Investments

4 investments dated 2023 · listed companies and verified rows first · show all

Iambic Therapeutics, Inc.Sep 2023SEC filingmedium confidence

BiotechSan Diego, US

Fred Manby(Executive Officer, Director)inThomas Miller(Executive Officer, Director)inNeil Josephson(Executive Officer)Michael Secora(Executive Officer)Pete Olson(Executive Officer)Chao Zhang(Executive Officer)

Board seatJishnu Bhattacharjee· per SEC Form D · $110M raise · filed Oct 2023

Co-investorsAbingworthNexus Ventures

Apollo.ioapollo.ioin𝕏Sep 2023 · $100M

Apollo provides an AI-powered platform designed for go-to-market teams to improve sales and marketing productivity.

AI & Machine LearningEnterprise SoftwareMarketing TechSales TechSan Francisco, US

Tim Zheng(Founder/CEO)inRay Li(Founder)inMatt Curl(Chief Executive Officer)Marcio Arnecke(Chief Marketing Officer)Adam Carr(Chief Revenue Officer)Phil Moon(Chief Financial Officer)

Co-investorsA*Angel Collective Opportunity FundBain Capital VenturesNewView CapitalPathlight VenturesStruck Capital+8 more

Fingerprintfingerprint.comin𝕏Sep 2023 · $33M

Fingerprint provides device identification and fraud detection services for online businesses, leveraging browser fingerprinting technology to identify devices and prevent fraud and bot activity.

AdTechCybersecurityEnterprise SoftwareSaaSChicago, US

Valentin Vasilyev(CTO and co-founder)Dan Pinto(Executive Officer, Director, Promoter)Valentin V.(Founder)in

BoardAbhishek Sharma(Director)in

Co-investorsCraft VenturesEntrepreneurs Roundtable Accelerator (ERA)Uncorrelated Ventures

Pandopandopooling.comin𝕏May 2023 · $30M

Pando provides income pooling and financial tools for founders, enabling them to diversify personal wealth through shared pools of future earnings while accessing liquidity products and a vetted peer community.

Fintech

Eric Lax(Founder)in

Co-investorsCore Venture CapitalCorrelation VenturesUlu VenturesChiratae VenturesCraft VenturesIron Pillar+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.